Robot vs. camera: which lung cancer surgery is better?
NCT ID NCT02617186
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares two types of minimally invasive lung cancer surgery: robotic-assisted surgery and video-assisted thoracoscopic surgery (VATS). About 446 people with early-stage non-small cell lung cancer will be randomly assigned to one of the two procedures. The main goal is to see if one approach leads to better quality of life 12 weeks after surgery, and also to compare costs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If robotic surgery proves better for quality of life or cost, it could become the preferred minimally invasive option for early-stage lung cancer.
- What could go wrong
- This is a comparative effectiveness study, not a test of a new treatment. Results may show no meaningful difference between the two surgical approaches.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
446 people
The number who actually took part.
- Start date
-
Jan 2016
- Expected to finish
-
Sep 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age \>/= 18 years 2. Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC) 3. Candidates for minimally invasive pulmonary lobectomy, as determined by the operating surgeon. Exclusion Criteria: 1. Clinical stage IIIb or IV NSCLC 2. Not a candidate for minimally invasive surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-small cell lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McMaster University / St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug combo targets stubborn KRAS lung cancer
- Smaller chest drain may speed recovery after lung cancer surgery
- Gut bacteria may hold clues to why some cancer treatments work better
- Breath-Tracking sensor aims to sharpen lung cancer scans
- Can PET scan signals predict who beats lung cancer with immunotherapy?
- Two-Drug combo takes aim at Hard-to-Treat lung cancer